Managed Care Consolidation Since the mid-1990’s, the managed care industry has seen significant consolidation

Managed Care Companies (as a Percentage of Total Market Capitalization)

United US Healthcare United 2% Aetna 2% 6% 3% Cigna 4% 2% 19% 9% Aetna 3% Humana 3% WellPoint Anthem 3% 12% 3% Healthsource 47% Cigna 15% Oxford 8% Foundation Humana Mid Atlantic 12% 9% Takecare Centene 13% 11% Health Systems 13% Other FHP International Other

1995 – Total $40.6 billion 2017 – Total $428.6 billion Top 5 = 67% of total Top 5 = 93% of total

______Source: CapitalIQ and industry research. 2017 as of 11/1/17. 1 Recent Stock Performance of Publicly Traded Health Plans Over the past year, in spite of legislative uncertainty, the managed care plans have seen a large increase in market value, well exceeding the rise in the S&P 500. They are trading at close to 52-week highs

2017 Stock Performance 90%

80% 76.8%

70%

59.6% 59.5% 60% 56.8%

50% 48.7% 43.6% 39.7% 40% 33.7%

30%

21.2% 20%

10%

0% S&P 500

______Note: Percentage change from 11/7/16 – 11/10/17 Source: CapitalIQ and industry research. 2 Managed Care Capital Deployment The earnings are deployed primarily for share repurchases and M&A, though capital expenditures (Cap Ex) are significant

Capital Deployment: 2007-2016 2016 & 2017 YTD Cap Ex for Leading Managed Care Firms

($ in millions) (1) (1) Company 2016 Capex (%) 2017 Q3 YTD Capex (%)

$270 (0.4%) $301 (0.7%) Dividend s 9% $584 (0.7%) $516 (0.8%)

$306 (0.8%) $301 (0.8%)

Repurch M&A ases $461 (1.2%) $340 (1.1%) 38% 53% (2) $527 (1.0%) $233 (0.9%)

$61 (1.3%) $43 (1.0%)

$176 (1.0%) $85 (0.6%)

$1,705 (0.9%) $1,391 (0.9%)

Represents ~$150bn of total capital deployed $105 (0.7%) $93 (0.7%)

______Source: Deutsche Bank, 2016 SEC Filings (1) Represents CapEx as a percentage of revenue (2) Humana reports 2016 and 2017 Q2 YTD 3 Cain Brothers’ Views on the Managed Care Markets From the beginnings of ACA through the uncertainty of Repeal/Replace/Reform, the managed care sector has been impacted more than any other sector in healthcare. We believe it will continue to strengthen regardless of what actions come out of Congress Key Themes

Government programs are the Activity expected around avenue to growth capabilities more than sales/mergers

Scale and diversification will drive Provider/payer collaboration consolidation and M&A Activity will accelerate

Disruptive innovation on the horizon?

4 MCO Penetration in Medicaid by Program Type The high acuity Medicaid populations offer a significant opportunity for growth for the Medicaid MCOs

Managed Care Expansion Opportunities

Managed Care # of Lives Penetration

Medicaid 60mm >70%

Aged, Blind & Disabled (ABD) 15mm <25%

Total MME 9mm <15% Market

Long Term Care 3mm <15%

______Source: Barclays 5

Selected Provider/Payer Partnerships

______Source: Company website 6

New York has a robust not-for-profit and independent health plan presence Though New York is not alone in this regard (e.g., WI, MA, NM) it is an important, and we believe ongoing, feature of the landscape, in spite of recent transactions

7 New York Medicaid Consolidation History Since the late-1990’s, the New York Medicaid industry has seen significant consolidation

New York mainstream Medicaid Managed Care has consolidated from 60 to 19 plans between 1997 and 2017 while significantly increasing enrollment. Expectation is that MLTC and similar programs will continue to experience the same consolidation.

Medicaid Managed Care Consolidation

Other (10 Plans with HIP of Greater New <2.3% Market Share) York 8.2% 3.4% Other (51 Plans with <4.2% Market MVP Health Plan Share) HIP/99 3.7% 40.4% 9.4%

Better Health Plan Excellus Fidelis Care 8.7% 3.8% [VALUE]

HealthFirst Affinity [VALUE] 5.1%

HealthPlus Oxford 8.0% 7.1%

MetroPlus HealthFirst 8.6% 20.9%

HIP of Greater United HealthCare New York 10.8% U.S. Healthcare 9.1% 4.4% Bronx Managed 4.6% Fidelis Care Healthcare 5.3% Systems 5.3% 1997 – 662,672 Enrollees 2017 – ~4.4 million Enrollees Managed Care Plans = 60 Managed Care Plans = 19

______Source: New York State Medicaid Enrollment Report Note: Includes mainstream Medicaid members only 8

New York Medicaid MLTC History With mandatory enrollment, the MLTC market has grown, as has the number of participants

In spite of this, numerous plans have exited in recent years, and we expect that trend to continue no matter what the status of/successor to FIDA

Medicaid MLTC Managed Care

[CATEGORY NAME](5 plans with <2.5% Market Share) [VALUE] [CATEGORY NAME] (16 plans with <2.5% Market Share) HHH [VALUE] 3.1% CCM 4.5% [CATEGORY Senior Health NAME] 5.6% [VALUE] GuildNet WellCare Centers Plan 30.9% 3.1% 9.9% VNA 2.8% Independent Elderplan 6.2% North Shore 6.6% 3.0% ElderServe Integra 6.0% HomeFirst 3.8% 13.1% Senior Independence Health 3.5% 7.4% Village Care VNS VNS 4.6% 6.7% 30.5% Agewell 4.6% Senior Whole GuildNet 4.8% 5.1%

2008 – 21,523 Enrollees 2017 – 189,071 Enrollees Managed Care Plans = 13 Managed Care Plans = 31

______Source: New York State Medicaid Enrollment Report Note: Includes mainstream Medicaid members only 9

What does this mean for smaller, regional health plans? As the industry continues to consolidate, smaller players will be able to stay competitive by strengthening client relationships, engaging in partnerships, and potentially merging with other organizations Competition will become more intense

Scale and capitalization will allow national players to acquire capabilities, Constraints on smaller plans’ (especially Potential for disruptive innovation diversify and lower administrative costs, non-for-profit) ability to raise (e.g. Aetna-CVS, Walmart) making it harder for smaller players to capital will make expansion more difficult and not just traditional competitors compete on price and retain customers

How will these plans compete?

` • Advantage of local market presence and reputation Relationships • Quality, customer service, and flexibility • Finding a sustainable niche to serve

• Back office joint-ventures, network sharing arrangements, best of breeds contracting Partnerships • Essential provider partnerships • Acquiring capabilities to create an integrated offering

• Robust valuations Merger/Sale • High capitalization gives bigger players an appetite for acquiring smaller companies

10 Major Themes in Healthcare

Moving More Care Into The Community Setting

Aggregation Of Physicians

Payer-Provider Vertical Integration Capital Allocated to Post-Acute Coordination Healthcare

Population Health Management

Technology-Enabled Healthcare

11 Current Credit Markets Snapshot There is a robust financing market for health care services companies, with representative lenders shown below. In general, lenders are looking for stability of revenue and EBITDA, organic and de novo growth opportunities, and $10 million+ of EBITDA visibility in the current market environment.

Representative Lenders

Senior Lenders and Unitranche

( (

Subordinated Debt

12 Welsh, Carson, Anderson & Stowe (WCAS) Healthcare Investment History WCAS is one example of how active private equity has been across the spectrum of health care services

______Source: Norton Rose Fulbright Conference 13

Managed Care The managed care risk businesses are not at the epicenter of private equity investment. However, there is increasing interest in the space, especially in governmental programs and specialty services

Cardinal Partners, FLAG Capital, HLM Venture CapitalG, Founders Fund, General Catalyst, Partners, Kleiner Perkins, New Capital Khosla Ventures, Lakestar, Ping An Ventures, 2016 Partners, Trident Capital, QuestMark, Thrive Capital Greenspring Associates, Waveland Ventures 2014

Athyrium Capital, First Round Capital, Sequoia Kinderhook Industries Capital 2016 2009

Bain Capital, Diamond Castle Holdings 2014 Leonard Green, GIC, Hellman & Friedman 2016

Blackstone, Credit Suisse and Goldman Sachs Stonehenge Growth Capital Partners 2005 2009

Centerbridge Partners Juggernaut Capital 2016 2016

Goldman Sachs, Pamplona Capital Management 2014

______Source: Company filings, Capital IQ, Wall Street research and Cain Brothers’ estimates 14

Acute Care Hospitals The vast majority of hospital beds are owned by not-for-profit or governmental sponsors, and this has not changed for decades. However, private equity is still involved, both directly and via partnerships

For-Profit Joint Ventures / Investments

Risk Sharing Aetna & Banner Health Agreement LifePoint Health

Apollo Global Tenet Management

Billings Clinic & The Carlyle Group & TPG RegionalCare Capital

Medical Properties TPG Capital Trust

Leonard Green & Partners Ventas

15 Home Health and Hospice Home health and hospice, both relatively fragmented markets, have seen tremendous interest by the private equity community

Private Equity Investments

Altaris Capital Partners Fulcrum Equity Partners Palladium Equity

Gemini Investors / Audax Group Patriarch Partners Plenary Partners

Bain Private Equity Generation Growth PNC Riverarch Capital Capital / J.H. Whitney Capital

Bell Health Investment Pouschine Cook Capital Graham Holdings Partners Management

Blue Wolf Capital H.I.G. Capital Psilos Group

Investors Management Boyne Capital Riverside Company Corporation

Levine Leichtman Capital Tenex Capital Capricorn Healthcare Partners Management

The Carlyle Group Linsalata Capital Partners Valor Equity Capital

Wellspring Capital Evolve Capital Oak Hill Capital Partners Management

Welsh, Carson, Anderson Formation Capital One Equity Partners & Stowe

Frazier Healthcare Onex Partners

16 Behavioral Health The same is true for behavioral health, especially with mental health parity, the opioid crisis, and lessening stigma associated with behavioral health

Private Equity Investments

Audax Group Linden

BBH MTS Health Investors

Bregal Partners Polaris / Oak HC/FT

Clearview Capital Ridgemont Equity Partners

Comvest Partners Riverside Company

Dobbs Management Group Vestar Capital Partners (Public)

FFL Webster Capital

Frazier Healthcare, NEA Wellspring Capital Management

H.I.G Welsh, Carson, Anderson & Stowe

Kohlberg & Company Wicks Group / The Jordan Company

17 New York Health Plan Association Conference

November 16, 2017 Disclaimer

Confidential

This document is for discussion purposes only and does not constitute advice of any kind, including tax, accounting, legal or regulatory advice, and Cain Brothers, a division of KeyBanc Capital Markets (“Cain Brothers”) is not and does not hold itself out to be an advisor as to tax, accounting, legal or regulatory matters. We recommend that you seek independent third party legal, regulatory, accounting and tax advice regarding the contents of this document. The matters discussed herein are subject to our review and assessment from a legal, compliance, accounting policy and risk perspective, as appropriate, following our discussion with you.

This document was prepared on a confidential basis solely for discussion between you and Cain Brothers and not with a view toward public disclosure. This document may contain information provided by third parties. This document, and any oral information provided in connection herewith, shall be treated as strictly confidential and may not be reproduced, distributed or disclosed, in whole or in part, except with our prior written consent and, if applicable, the prior written consent of any third-party information provider. Cain Brothers assumes no obligation to update or otherwise revise these materials.

No representation or warranty, express or implied, is made as to the accuracy or completeness of the information contained herein and nothing contained herein is, or shall be relied upon as, a representation or warranty, whether as to the past or the future. Cain Brothers and our affiliates and our and their respective officers, employees and agents, as well as any third-party information providers, expressly disclaim any and all liability which may be based on this document and any errors therein or omissions therefrom.

This document does not constitute an offer or solicitation to sell or purchase any securities and is not a commitment by Cain Brothers or any of its affiliates to provide or arrange any financing for any transaction or to purchase any security or act as an agent or advisor or in any other capacity in connection therewith. This document does not constitute a recommendation to pursue, and is not intended to provide the sole basis for evaluating, a particular transaction, and you retain full responsibility for the decision to pursue any specific transaction discussed herein or otherwise.

“Cain Brothers, a division of KeyBanc Capital Markets” is a trade name of Cain Brothers & Company, LLC Member FINRA/SIPC. Cain Brothers & Company, LLC is a wholly-owned subsidiary of KeyBanc Capital Markets Inc. Member NYSE/FINRA/SIPC.

Cain Brothers & Company, LLC, KeyBanc Capital Markets Inc. and KeyBank National Association are separate but affiliated companies. Securities products and services are offered by Cain Brothers & Company, LLC, KeyBanc Capital Markets Inc. and their respective licensed securities representatives. Banking products and services are offered by KeyBank National Association. Credit products are subject to credit approval.